Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials

New York – February 15, 2022 – Medidata, a Dassault Systèmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for clinical trials. Medidata will open access to its Patient Insights Program as part of a new offering to incorporate a patient-centric approach to the design and development of clinical trial protocols and technologies. 

The Patient Insights Program provides access to Medidata’s experienced and diverse Patient Insights Board, using innovative workshops called design studios to guide the creation of protocols and patient-facing solutions to improve clinical trial experiences, expedite clinical trial delivery timelines, and bring therapies to market faster.
“Medidata is the first company to institute a formal process of infusing the patient perspective into the software development life cycle to create technical solutions improving the overall patient experience,” said Alicia Staley, vice president, Patient Engagement at Medidata. “We are opening up access to this program to ultimately make clinical trials an option for more people, including those historically left behind by clinical trials.”

“Patient centricity” has been a buzzword for nearly a decade but most clinical studies are designed with little to no direct input from the patients/caregivers that are expected to enroll in and adhere to a clinical research study. Patient engagement has mostly been limited to sporadic and superficial sessions, with little impact on reducing patient burden or improving enrollment, retention, and experience.

“Participating in a Patient Design Studio with Medidata's patient advocates to co-create, edit and inform our Clinical Trial Readiness Tool was invaluable,” said Erin Miller, development manager/ IMPACT and PATH Program liaison for Lazarex Cancer Foundation. “This one-of-a-kind tool will help us understand each patient’s individual journey and allow us to get them the resources they need to successfully stay in their clinical trial, giving them hope and a chance for an improved cancer health outcome.”

The Medidata Patient Insights team has run over 20 design studios to provide feedback and insights into Medidata's products. Medidata’s Patient Centricity by Design is a formal methodology by which the patient perspective is infused into the software development life cycle. This video shows how Medidata develops empathetic technical solutions by including patients in our work.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit